Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug
Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…
CertaraOctober 21, 2016
Rare Disease and Orphan Drug Development
There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…
CertaraAugust 3, 2016
Model-based Meta-analysis: An Innovative Methodology Comes of Age
MBMA integrates internal and external drug development data to inform proprietary commercial and R&D decisions.…
CertaraJuly 14, 2016
